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Abstract
Background: Substitution with opioid-agonists (e.g., methadone) has shown to be an effective treatment for
chronic long-term opioid dependency. Survival sex work, very common among injection drug users, has been
associated with poor Opioid Agonist Treatment (OAT) engagement, retention and response. Therefore, this study
was undertaken to determine factors associated with engaging in sex work among long-term opioid dependent
women receiving OAT.
Methods: Data from a randomized controlled trial, the North American Opiate Medication Initiative (NAOMI),
conducted in Vancouver and Montreal (Canada) between 2005-2008, was analyzed. The NAOMI study compared
the effectiveness of oral methadone to injectable diacetylmorphine or injectable hydromorphone, the last two on a
double blind basis, over 12 months. A research team, independent of the clinic services, obtained outcome
evaluations at baseline and follow-up (3, 6, 9, 12, 18 and 24 months).
Results: A total 53.6% of women reported engaging in sex work in at least one of the research visits. At treatment
initiation, women who were younger and had fewer years of education were more likely to be engaged in sex
work. The multivariate logistic generalized estimating equation regression analysis determined that psychological
symptoms, and high illicit heroin and cocaine use correlated with women’s involvement in sex work during the
study period.
Conclusions: After entering OAT, women using injection drugs and engaging in sex work represent a particularly
vulnerable group showing poorer psychological health and a higher use of heroin and cocaine compared to
women not engaging in sex work. These factors must be taken into consideration in the planning and provision of
OAT in order to improve treatment outcomes.
Trial Registration: NCT00175357.
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1. Background
Opioid dependence, frequently manifested as heroin
dependence, is a chronic illness that, when untreated,
can result in adverse health consequences such as
blood-borne viral infections, endocarditis and drug over-
doses [1,2]. Illicit opioid use is also associated with
severe psychosocial problems such as homelessness,
unemployment, loss of family bonds, and illegal activity
[3]. Survival sex work is very common among street
drug users and has been associated with increased drug
related harms [4-7]. Although data indicate that women
as well as men using drugs engage in sex work, women
who use injection drugs are more likely to be involved
in survival sex work compared to men [4,8,9].
Data suggest that women who are injection drug users
(IDU) and engage in sex work present greater vulner-
abilities compared to non-sex workers using injection
drugs. For example, they are more likely to have
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[4,10-12] and fewer years of education [12]. These
women are also more likely to report daily injection her-
oin use [10], higher rates of cocaine use [4] and binge
drug use [13]. These observations suggest that women
who use injection drugs and engage in sex work may be
more vulnerable to adverse physical and psychological
consequences of injection drug use.
Chronic health conditions and infectious diseases,
such as human immunodeficiency virus (HIV) infection
[14,15], hepatitis C [16] and sexually transmitted infec-
tions (STI) are highly prevalent among female sex work-
ers using injection drugs. This has been supported by
s t u d i e ss h o w i n gt h a tH I Vr i s k behaviours, including
sharing injection equipment [4,10,11,17] and inconsis-
tent condom use with clients [10,17] are common risk
behaviours. Moreover, a recent study found that enga-
ging in risky injection practices (e.g., sharing injection
equipment) was more likely among female sex workers
with psychological distress [17], indicating an association
between psychological health and disease risk. Psycholo-
gical health has previously been measured among sex
workers and non-sex workers accessing opioid agonist
therapy (OAT). In a sample of injection drug using
women accessing MMT [12], it was determined that sex
workers had greater psychological symptoms including
depression, anxiety, psychosis and hostility, compared to
women not involved in sex work.
OAT (for example with methadone or buprenorphine) is
widely considered the most effective intervention for
opioid dependency [18]. OAT has been proven effective at
reducing illicit drug use and illegal activities, HIV infec-
tions, as well as improving general health and psychosocial
adjustment [2,18-20]. There is evidence showing that
involvement in sex work may be negatively associated with
OAT access and outcomes, including reduced access to
care [4,21,22] and early withdrawal from a low-threshold
program [23]. Moreover, a recent randomized clinical trial
(RCT) comparing Heroin Assisted Treatment (HAT) to
Methadone Maintenance Treatment (MMT) found female
sex workers had higher illicit drug use and poorer health
outcomes after 12 months of treatment relative to those
not engaged in sex work [8].
The studies described above suggest that among
women using injection drugs, sex work is a factor that
may deter women from being engaged, retained and
responding to OAT. However, the factors that are asso-
ciated with engaging in sex work after entering treat-
ment are not well understood. The present study aims
to determine if health (physical, mental, social), illicit
drug use and treatment retention were associated with
engaging in sex work after initiating OAT in a cohort of
long-term opioid injection drug users.
2. Methods
Design, Setting and Participants
The North American Opiate Medication Initiative
(NAOMI) was an open-label, phase III RCT comparing
supervised injected diacetylmorphine (the active ingredi-
ent in heroin) and oral methadone in the treatment of
long-term opioid dependence. Participants’ profile, study
design, methodology and results of the parent study have
been published elsewhere [24-26]. Briefly, eligible partici-
pants were at least 25 years of age, with a minimum of 5
years of opioid dependence, current daily injection of
opioids, at least two prior treatment attempts for opioid
dependence (including at least one OAT), and no enrol-
ment in OAT within the prior 6 months.
A total of 251 individuals were randomized to receive
oral methadone (n = 111) or injectable opioids (on a
double blind basis: diacetylmorphine, n = 115; hydro-
morphone, n = 25). Oral methadone was dispensed daily
and injectable medications were administered up to
three times daily under the supervision of nursing staff.
Participants were also offered psychosocial services and
primary care on site and all services were delivered in a
patient-centred fashion [27]. Medications were provided
for 12 months. Since injectable medications were not
licensed for addiction treatment, an additional 3-month
period was provided to taper and transition those in the
injection group to other treatment modalities (primarily
methadone). All participants provided written informed
consent and the study was approved by the University
of British Columbia/Providence Health Care and Centre
de Recherche du Centre Hospitalier de l’université de
Montréal research ethics boards.
Measures
A research team, independent of the clinic services,
obtained outcome evaluations at baseline and follow-up
( 3 ,6 ,9 ,1 2 ,1 8a n d2 4m o n t h s ) ,u s i n gt h eE u r o p e a n
Addiction Severity Index ([EuropASI]; [28]), the Mauds-
ley Addiction Profile ([MAP]; [29]) and health related
quality of life instrument- Euroquol ([EQ5D]; [30]). For
the purpose of the present study, participants were con-
sidered retained at each evaluation if they received
addiction treatment on at least 20 of the 30 days in the
month prior to the evaluation.
Information related to sex work was obtained from
the Employment/Support Status questionnaire of the
EuropASI. Participants responded dichotomously to
whether or not they received money from ‘Prostitution’
in the prior 30 days.
Analysis
Continuous variables were described by means, median,
standard deviations and interquartile range, while
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variables. A multivariate logistic regression model esti-
mated by generalized estimating equations (GEE) algo-
rithm for repeated measures was used to determine
factors (socio-demographic, substance use, treatment
history, physical and psychological health, etc.) asso-
ciated with reporting sex work at baseline. To evaluate
the relationship between sex work and study variables
measured during the 12 month treatment period and up
to 24 months follow-up, a bivariate logistic regression
analysis, adjusted by baseline sex trade involvement (i.e.,
a logistic regression model with baseline sex trade invol-
vement and one additional independent variable) was
used. Variables that were determined significant at p
value ≤ 0.1 in bivariate analyses were included in the
adjusted multivariate logistic regression model, esti-
mated by generalized estimating equations (GEE) algo-
rithm for repeated measures. Ethnicity, age, study site,
randomization arm and treatment retention were added
throughout the group variable and final model selec-
tions. Odds ratios (OR) and 95% confidence intervals
(CI) were calculated. Missing observations were consid-
ered as missing in the analysis.
Only four of 154 (1.3%) men reported engaging in sex
work; therefore, analyses were performed for women
only. Of the 97 women entering treatment, we obtained
outcome measures for 81 women at 24 months (83.5%).
3. Results
A total of 52 (53.6%) women receiving oral and inject-
able medications reported being involved in sex work in
at least one of the seven research visits (Table 1). Thir-
teen women who were not engaged in sex work at base-
line reported doing so at some point during the follow-
up period, while 10 of the 52 women were consistently
involved in sex work at each of the seven research visits.
The multivariate analysis of factors associated with base-
line sex work indicated that younger women (OR for
every 5 year increase in age = .76; 95% CI = .57,1.00; p
= .05) and women with less education (OR for each
additional year of education = .81; 95% CI = .66,1.01; p
= .055) were more likely to engage in sex work.
The bivariate logistic regression analysis, adjusted by
baseline sex trade (Table 2), indicated that treatment
retention and health related quality of life were inversely
associated with sex work. Sex work was more likely
among women with poorer scores in social relations,
greater physical and psychological health symptoms and
more days of illicit heroin, cocaine and injection drug
use in the prior month. Women considered to have a
high (≥ 20) or medium (9-19) number of days of injec-
tion drug use in the past 30 days were more likely to
report sex work compared to women with low days (≤
8) of injection. In addition, compared to women who
injected the least amount of times per day (≤ 3), those
with the most frequent daily injection (≥ 7) were more
likely to report sex work in the prior 30 days. There was
a suggestion that injectable treatment had a protective
effect on engagement in sex work with an adjusted odds
ratio of .83. However, this was not statistically signifi-
cant. With only about 45 women in each arm of
NAOMI, the power to detect an odds ratio of .8 is vir-
tually non-existent.
In the multivariate logistic regression GEE model
(Table 3), women with more days of heroin (OR = 1.26;
95% CI = 1.05, 1.15; p = .01) and cocaine use (OR =
1.36; 95% CI = 1.16, 1.60; p < .001) and greater psycho-
logical symptoms (OR = 1.07; 95% CI = 1.03, 1.11; p <
.001) in the prior month were more likely to engage in
sex work compared to those with less psychological
symptoms, and days of heroin and cocaine use.
4. Discussion
The aim of this study was to determine factors asso-
ciated with engaging in sex work among long-term
opioid injection drug users receiving OAT in the frame
of a clinical trial. A higher proportion of women (53.6%)
compared to men (1.3%), reported engaging in sex work
Table 1 Total number of women reporting sex trade
Women Total N = 97
Sex trade n with sex trade % (out of total N) Total N with visit % (out of those with visit)
Ever (a) 52 53.6 97 53.6
Baseline 42 43.3 97 43.3
3 months 28 28.9 89 31.5
6 months 21 21.6 86 24.4
9 months 23 23.7 88 26.1
12 months 23 23.7 92 25.0
18 months 18 18.6 87 20.7
24 months 17 17.5 81 21.0
(a) Reported ever being involved in sex trade at some point during the evaluation period
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to 24 months. At treatment entry, age and education
were associated with sex work, while during the study
period, psychological symptoms and frequent heroin
and cocaine use in the prior 30 days were associated
with sex work.
At treatment initiation, women who were younger and
had fewer years of education were more likely to be
engaged in sex work, factors which have previously been
associated with sex work among women using injection
drugs [4,10,12]. Housing, ethnicity and incarcerations
have also been documented in previous studies [4]. The
lack of such associations in the present study reflects
the homogeneity of the NAOMI sample, possibly due to
study inclusion criteria.
When examining factors associated with sex work
involvement during the study period, women with
poorer treatment outcomes were more likely to engage
in sex work. Specifically, lower treatment retention,
poorer scores in social relations and health related
quality of life, more days of illicit drug use, injection
drug use, and more frequent daily injection in the
prior 30 days. These findings indicate that sex work
was more likely among a subgroup of women who did
n o tf u l l yb e n e f i tf r o mO A T ,an o t e w o r t h yf i n d i n gc o n -
sidering that OAT has shown to reduce many of the
harms associated with long-term heroin use [2,18].
Moreover, in the present study women who were
retained successfully in OAT were less likely to be
involved in sex work and therefore experienced a
reduced vulnerability to harms caused by injection
drug use. While this is not a causal association, it indi-
cates that those involved in sex work were more likely
to drop-out of treatment.
In the multivariate model, psychological symptoms
and high illicit heroin and cocaine use in the prior 30
days were associated with sex work. Similarly, previous
studies have found that sex workers accessing MMT
[12] and syringe exchange programs [10] presented with
higher psychological distress compared to women not
engaged in sex work. In addition, a higher use of sub-
stances [13], including more frequent daily heroin and
cocaine use [4,10] has also been reported among injec-
tion drug using women who also engage in sex work.
T h er e s u l t so ft h ep r e s e n ts t u d yc o m p l e m e n tp r i o r
research in the context of a prospective design that
allowed us to capture predictors of sex work involve-
ment over a 24 month study period. After engaging
these participants in OAT, women who continued enga-
g i n gi ns e xw o r kw e r em o r el i k e l yt oc o n t i n u eu s i n g
heroin and cocaine, independent of OAT retention.
Thus, many women continued engaging in survival sex
work and using illicit heroin, despite that OAT improves
retention and reduces illicit heroin use. The complexity
Table 2 Univariate logistic regression analysis, adjusted
by baseline sex trade, of variables associated with
engaging in sex trade after baseline
Variable (a) OR p-value
(95% CI)
Treatment Retention: (b) 0.41 0.001
Yes vs. No (0.24, 0.68)
Social Relations: (c) 1.08 0.009
Every 0.2 unit increase (1.02, 1.14)
Days injecting drugs: (c) 6.40 < 0.001
High (≥ 20) vs. Low (≤ 8) (3.37,12.18)
3.26 0.002
Medium (9-19) vs. Low (≤ 8) (1.53, 6.95)
Times injecting on a typical day: (d) 5.40 0.001
High (≥ 7) vs. Low (≤ 3) (2.05, 14.22)
Days with heroin use: 5.12 < 0.001
Every 5 day increase (2.76, 9.52)
Days with cocaine use: 5.92 < 0.001
Every 5 day increase (2.77, 12.66)
EQ5D: (e) 0.99 0.019
Every 0.1 unit increase (0.98, 1.00)
Physical health symptoms: (d) 1.05 0.02
Every 1 unit increase (1.01, 1.09)
Psychological symptoms: (d) 1.09 < 0.001
Every 1 unit increase (1.06, 1.13)
OR: Odds ratios; CI: Confidence Interval
(a) All variables refer to the prior month;
(b) Retention to treatment: at least 20 out of prior 30 days;
(c) EuropASI (European version of the Addiction Severity Index). Sub-scale
scores range from 0 to 1; higher scores are indicative of more severe
problems;
(d) MAP (Maudsley Addiction Profile). Scores range from 0 to 40; higher scores
are indicative of more symptoms;
(e) EQ5D (Euroquol) Scores range from 0 to 1; higher scores are indicative of
less severe problems; EQ5D index score with U.S. weights.
Table 3 Multivariate GEE model of predictors of
engaging in sex trade after baseline
Variable (a) OR p-value
(95% CI)
Heroin use: 1.26 0.01
Every 5 day increase (1.05, 1.15)
Cocaine use: 1.36 < 0.001
Every 5 day increase (1.16, 1.60)
Psychological symptoms: (b) 1.07 < 0.001
Every 1 unit increase (1.03, 1.11)
OR: Odds ratios; CI: Confidence Interval;
Model adjusted by ethnicity, interaction between age and randomization arm,
treatment retention (not significant) and study site and baseline sex work
(significant).
(a) All variables refer to the prior month;
(b) MAP (Maudsley Addiction Profile). Scores range from 0 to 40; higher scores
are indicative of more symptoms.
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impact on sex work engagement requires further study.
Education is regarded as a strong indicator of social
and health-related inequalities [31], and women with
fewer years of education were more likely to engage in
sex work at treatment initiation. These findings indicate
that women with less education experience further vul-
nerabilities even within a population with very low
socio-economic status. Therefore, those who provide
addiction treatment services must consider this special
circumstance, acknowledging women’s financial needs
and the stigma attached to sex work, so that services
and policies do not further exclude these groups.
The present study focuses on long-term opioid injec-
tion drug using women with and without involvement
in sex work. It is well known that opioid-dependent
individuals often show poor mental and physical health
as well as poor psychosocial functioning, especially after
long-term use [3,32,33]. There is also growing research
evidence among women and men accessing OAT
demonstrating that women enter treatment with worse
physical and psychological health [8,9], as well as higher
opioid and stimulant use [34,35,35]. Some evidence has
also suggested that women have poorer OAT outcomes
compared to men [8,9]. Therefore, women using injec-
tion drugs represent a particularly important group in
the provision of effective addiction treatment.
Unexpectedly, there was no association between victi-
mization (e.g., physical, emotional, and sexual abuse)
and sex work in the present study. Previous studies have
shown high rates of physical and sexual abuse in sex
workers’ childhood, and later victimization by partners
[12,36] and clients in adulthood [37]. Moreover, in a
cohort study of youth using substances, childhood sex-
ual abuse was independently associated with sex work
[38]. One possible explanation for the absence of this
expected association may be related to the measure of
victimization. The Addiction Severity Index (ASI) has
been used to evaluate abuse in several studies [39], mea-
suring victimization with a general question (e.g., “have
you ever been physically or sexually abused?”). There-
fore, [40-42] details regarding the nature of the event,
which might account for the associations between victi-
mization and sex work, are undetermined [43,44].
Limitations of the NAOMI study have been discussed
elsewhere [24,25]. It should be noted that the analysis
were intent-to-treat, therefore, some of the higher inten-
sity drug use occurred in participants who were not
receiving the treatments as provided in the study (oral
and injectable arms). Several gender sensitive and sex
work specific-related questions were not part of the
study evaluation package (e.g., partner’s use of illicit
substances, income earned from sex work to support
heroin use), that data would have provided a more
detailed picture of the situation. In addition, the trial
was not designed to investigate factors associated with
sex work and we had a small sample size; however it
provided an opportunity to obtain valuable information
on this topic in the context of women receiving OAT.
I no r d e rt ob e t t e rc o n c e p t u a l i z et h er e l a t i o n s h i p
between high intensity drug use and sex work, addi-
tional data regarding the reasons for sex work involve-
ment during treatment, the proportion of earnings used
from sex work to support illicit drug use, and informa-
tion regarding the people whod e p e n do na ni n d i v i d u a l
involved in sex work, should be captured..
The findings presented suggest that participation in
NAOMI positively affected the pattern of sex work,
showing a decline from enrolment to 24 months fol-
low-up. At treatment entry, all NAOMI participants
had not received any treatment for the six months
prior to study enrolment (as per inclusion criteria);
therefore considered un-treated despite the available
options (e.g., methadone treatment). Engagement in
treatment was associated with a decline in sex work
over time. This particular group would have likely
remained outside of addiction treatment services, and
likely only initiated treatment for the opportunity to
receive injectable diacetylmorphine. Certainly,
approaches that improve treatment engagement (such
as medically prescribed diacetylmorphine) for long-
term treatment refractory heroin injectors, must be
supported by current policies.
5. Conclusion
Findings of this study suggest that injection drug using
women engaged in sex work represent a highly vulner-
able group with poorer psychological health and a
greater use of heroin and cocaine while receiving OAT.
Future research should aim to better understand the cir-
cumstances around illicit drug use and sex work among
opioid-dependent individuals’ receiving OAT, as these
activities impact treatment outcomes and the addiction
recovery process. In addition, mixed methods studies
exploring sex workers’ perceptions of OAT and barriers
to treatment engagement may provide valuable informa-
tion for the development of future interventions and
design of tailored services which should aim to simulta-
neously reduce the harms associated with injection drug
use and sex work.
Acknowledgements
The study was funded through an operating grant by the Canadian
Institutes of Health Research (CIHR) with additional support from the Canada
Foundation for Innovation, the Canada Research Chairs Program, the
University of British Columbia, Providence Health Care, the University of
Montreal, Centre de Recherche et Aide aux Narcomanes, the Government of
Quebec, Vancouver Coastal Health Authority and the BC Centre for Disease
Control. CIHR had no further role in study design; in the collection, analysis
Marchand et al. Harm Reduction Journal 2012, 9:8
http://www.harmreductionjournal.com/content/9/1/8
Page 5 of 7and interpretation of data; in the writing of the report; or in the decision to
submit the paper for publication.
The authors wish to acknowledge the dedication of N. Laliberté, C. Gartry, K.
Sayers, P-A Guevremont, P. Schneeberger, K. Lock, J. Chettiar, J. Lawlor, P.
Pelletier, S. Maynard, M-I Turgeon, G. Brunelle, A. Chan, S. MacDonald, T.
Corneil, J. Geller, S. Jutha, S. Chai, M. Piacsezna, S. Sizto, the many remaining
staff and members of the DSMB (A. Marlatt, N. El-Guebaly, J. Raboud, D. Roy).
The authors also wish to recognize the many U.S. and Canadian (J. Rehm, B.
Fischer) scientists who contributed to the early design discussions but
ultimately were unable to participate in the trial. Most importantly, the
authors wish to acknowledge and thank the NAOMI trial participants.
Author details
1Centre for Health Evaluation & Outcome Sciences, Providence Health Care,
St. Paul’s Hospital 620B-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
2School of Population and Public Health, University of British Columbia, 2206
East Mall Vancouver, BC, V6T 1Z3, Canada.
3Centre for Addiction Research
BC, University of Victoria, 2300 McKenzie Ave, Victoria, BC, V8P 5C2, Canada.
4Northern Ontario School of Medicine, 935 Ramsey Lake Road, Sudbury, ON,
P3E 2C6, Canada.
5Centre de Recherche du Centre Hospitalier de l’Université
de Montréal (CHUM), 1058 St-Denis Montréal, QC, H2X 3J4 Canada.
Authors’ contributions
MTS, SB, DM made substantial contributions to conception and design of
the study; MTS, SB, DM, EOJ and DG made substantial contributions to
acquisition of data, and analysis and interpretation of data; KM made
substantial contributions to analysis and interpretation of data. The first (KM),
second (EOJ) and last author (MTS) wrote the first draft of the paper, the
senior statistician (DG) performed the data analyses. All authors critically
revised the manuscript for important intellectual content. The final decision
about publishing the paper was made by all the authors.
Competing interests
The authors declare that they have no competing interests.
Received: 30 May 2011 Accepted: 25 January 2012
Published: 25 January 2012
References
1. Kuyper LM, Hogg RS, Montaner JSG, Schechter MT, Wood E: The Cost of
Inaction on Hiv Transmission Among Injection Drug Users and the
Potential for Effective Interventions. Journal of Urban Health-Bulletin of the
New York Academy of Medicine 2004, 81:655-660.
2. Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R: Substitution treatment
of injecting opioid users for prevention of HIV infection. Cochrane
Database Syst Rev 2008, CD004145.
3. March JC, Oviedo-Joekes E, Romero M: Drugs and social exclusion in ten
European cities. Eur Addict Res 2006, 12:33-41.
4. Spittal PM, Bruneau J, Craib KJ, Miller C, Lamothe F, Weber AE, Li K,
Tyndall MW, O’Shaughnessy MV, Schechter MT: Surviving the sex trade: a
comparison of HIV risk behaviours among street-involved women in two
Canadian cities who inject drugs. AIDS Care 2003, 15:187-95.
5. Mehrabadi A, Craib KJ, Patterson K, Adam W, Moniruzzaman A, Ward-
Burkitt B, Schechter MT, Spittal PM: The Cedar Project: a comparison of
HIV-related vulnerabilities amongst young Aboriginal women surviving
drug use and sex work in two Canadian cities. Int J Drug Policy 2008,
19:159-68.
6. Chettiar J, Shannon K, Wood E, Zhang R, Kerr T: Survival sex work
involvement among street-involved youth who use drugs in a Canadian
setting. J Public Health (Oxf) 2010, 32:322-7.
7. Shannon K, Bright V, Gibson K, Tyndall MW: Sexual and drug-related
vulnerabilities for HIV infection among women engaged in survival sex
work in Vancouver, Canada. Can J Public Health 2007, 98:465-9.
8. Eiroa-Orosa FJ, Verthein U, Kuhn S, Lindemann C, Karow A, Haasen C,
Reimer J: Implication of gender differences in heroin-assisted treatment:
results from the German randomized controlled trial. Am J Addict 2010,
19:312-8.
9. Oviedo-Joekes E, Guh D, Brissette S, Marchand K, Marsh D, Chettiar J,
Nosyk B, Krausz M, Anis A, Schechter MT: Effectiveness of
diacetylmorphine versus methadone for the treatment of opioid
dependence in women. Drug Alcohol Depend 2010.
10. Paone D, Cooper H, Alperen J, Shi Q, Des Jarlais DC: HIV risk behaviours of
current sex workers attending syringe exchange: the experiences of
women in five US cities. AIDS Care 1999, 11:269-80.
11. Kuyper LM, Palepu A, Kerr T, Li K, Miller CL, Spittal PM, Hogg RS,
Montaner JSG, Wood E: Factors Associated With Sex-Trade Involvement
Among Female Injection Drug Users in a Canadian Setting. Addiction
Research & Theory 2005, 13:193-199.
12. El-Bassel N, Simoni JM, Cooper DK, Gilbert L, Schilling RF: Sex trading and
psychological distress among women on methadone. Psychol Addict
Behav 2001, 15:177-84.
13. Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, Wood E: Binge
Drug Use Independently Predicts HIV Seroconversion Among Injection
Drug Users: Implications for Public Health Strategies. Subst Use Misuse
2006, 41:199-210.
14. Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE: The trading of
sex for drugs or money and HIV seropositivity among female
intravenous drug users. Am J Public Health 1994, 84:382-7.
15. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR: Sexual
transmission of HIV-1 among injection drug users in San Francisco, USA:
risk-factor analysis. Lancet 2001, 357:1397-401.
16. Miller CL, Spittal PM, LaLiberte N, Li K, Tyndall MW, O’Shaughnessy MV,
Schechter MT: Females experiencing sexual and drug vulnerabilities are
at elevated risk for HIV infection among youth who use injection drugs.
J Acquir Immune Defic Syndr 2002, 30:335-41.
17. Gu J, Lau JT, Chen H, Tsui H, Ling W: Prevalence and factors related to
syringe sharing behaviours among female injecting drug users who are
also sex workers in China. Int J Drug Policy 2010.
18. Haasen C, van den Brink W: Innovations in agonist maintenance
treatment of opioid-dependent patients. Curr Opin Psychiatry 2006,
19:631-636.
19. Ward J, Hall W, Mattick RP: Role of maintenance treatment in opioid
dependence. Lancet 1999, 353:221-6.
20. Amato L, Davoli M, A Perucci C, Ferri M, Faggiano F, P Mattick R: An
overview of systematic reviews of the effectiveness of opiate
maintenance therapies: available evidence to inform clinical practice
and research. J Subst Abuse Treat 2005, 28:321-9.
21. Callon C, Wood E, Marsh D, Li K, Montaner J, Kerr T: Barriers and
facilitators to methadone maintenance therapy use among illicit opiate
injection drug users in Vancouver. J Opioid Manag 2006, 2:35-41.
22. Kerr T, Marsh D, Li K, Montaner J, Wood E: Factors associated with
methadone maintenance therapy use among a cohort of polysubstance
using injection drug users in Vancouver. Drug Alcohol Depend 2005,
80:329-35.
23. Perreault M, Rousseau M, Lauzon P, Mercier C, Tremblay I, Héroux M:
Determinants of Retention in a Canadian Low-Threshold Methadone
Maintenance Program. Journal of Maintenance in the Addictions 2007,
3:37-51.
24. Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A,
Schechter MT: Diacetylmorphine versus methadone for the treatment of
opioid addiction. N Engl J Med 2009, 361:777-86.
25. Oviedo-Joekes E, Nosyk B, Marsh D, Guh D, Brissette S, Gartry C, Krausz M,
Anis A, Schechter MT: Scientific and political challenges in North
America’s first randomized controlled trial of heroin-assisted treatment
for severe heroin addiction: Rationale and design of the NAOMI Study.
Clinical Trials 2009, 6:261-271.
26. Oviedo-Joekes E, Nosyk B, Brissette S, Chettiar J, Schneeberger P, Marsh DC,
Krausz M, Anis A, Schechter MT: The North American Opiate Medication
Initiative (NAOMI): Profile of Participants in North America’s First Trial of
Heroin-Assisted Treatment. J Urban Health 2008, 85:812-25.
27. Health Canada Best practices in methadone maintenance treatment.
Ontario, Canada.: Minister of Public Works and Government Services
Canada; 2002.
28. Kokkevi A, Hartgers C: EuropASI: European adaptation of a
multidimensional assessment instrument for drug and alcohol
dependence. European Addiction Research 1995, 1:208-210.
29. Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P, Edwards C,
Strang J: The Maudsley Addiction Profile (MAP): a brief instrument for
assessing treatment outcome. Addiction 1998, 93:1857-67.
30. van der Zanden BP, Dijkgraaf MG, Blanken P, de Borgie CA, van Ree JM, van
den Brink W: Validity of the EQ-5D as a generic health outcome
Marchand et al. Harm Reduction Journal 2012, 9:8
http://www.harmreductionjournal.com/content/9/1/8
Page 6 of 7instrument in a heroin-dependent population. Drug Alcohol Depend 2006,
82:111-8.
31. Jarrin I, Lumbreras B, Ferreros I, Perez-Hoyos S, Hurtado I, Hernandez-
Aguado I: Effect of education on overall and cause-specific mortality in
injecting drug users, according to HIV and introduction of HAART. Int J
Epidemiol 2007, 36:187-94.
32. Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD: Longitudinal
patterns of drug injection behavior in the ALIVE Study cohort,1988-
2000: description and determinants. Am J Epidemiol 2003, 158:695-704.
33. Hser YI, Hoffman V, Grella CE, Anglin MD: A 33-year follow-up of narcotics
addicts. Arch Gen Psychiatry 2001, 58:503-8.
34. Acharyya S, Zhang H: Assessing sex differences on treatment
effectiveness from the drug abuse treatment outcome study (DATOS).
Am J Drug Alcohol Abuse 2003, 29:415-44.
35. Stewart D, Gossop M, Marsden J, Kidd T, Treacy S: Similarities in outcomes
for men and women after drug misuse treatment: results from the
National Treatment Outcome Research Study (NTORS). Drug Alcohol Rev
2003, 22:35-41.
36. Gilchrist G, Gruer L, Atkinson J: Comparison of drug use and psychiatric
morbidity between prostitute and non-prostitute female drug users in
Glasgow, Scotland. Addict Behav 2005, 30:1019-23.
37. El-Bassel N, Witte SS, Wada T, Gilbert L, Wallace J: Correlates of partner
violence among female street-based sex workers: substance abuse,
history of childhood abuse, HIV risks. AIDS Patient Care STDS 2001,
15:41-51.
38. Stoltz JA, Shannon K, Kerr T, Zhang R, Montaner JS, Wood E: Associations
between childhood maltreatment and sex work in a cohort of drug-
using youth. Soc Sci Med 2007, 65:1214-21.
39. Charney DA, Palacios-Boix J, Gill KJ: Sexual abuse and the outcome of
addiction treatment. Am J Addict 2007, 16:93-100.
40. Kang SY, Deren S, Goldstein MF: Relationships between childhood abuse
and neglect experience and HIV risk behaviors among methadone
treatment drop-outs. Child Abuse Negl 2002, 26:1275-89.
41. Pirard S, Sharon E, Kang SK, Angarita GA, Gastfriend DR: Prevalence of
physical and sexual abuse among substance abuse patients and impact
on treatment outcomes. Drug Alcohol Depend 2005, 78:57-64.
42. Tiet QQ, Finney JW, Moos RH: Recent sexual abuse, physical abuse,
suicide attempts among male veterans seeking psychiatric treatment.
Psychiatr Serv 2006, 57:107-13.
43. Langeland W, Draijer N, van den Brink W: Assessment of lifetime physical
and sexual abuse in treated alcoholics. Validity of the Addiction Severity
Index. Addict Behav 2003, 28:871-81.
44. Najavits LM, Weiss RD, Reif S, Gastfriend DR, Siqueland L, Barber JP,
Butler SF, Thase M, Blaine J: The Addiction Severity Index as a screen for
trauma and posttraumatic stress disorder. J Stud Alcohol 1998, 59:56-62.
doi:10.1186/1477-7517-9-8
Cite this article as: Marchand et al.: Sex work involvement among
women with long-term opioid injection drug dependence who enter
opioid agonist treatment. Harm Reduction Journal 2012 9:8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Marchand et al. Harm Reduction Journal 2012, 9:8
http://www.harmreductionjournal.com/content/9/1/8
Page 7 of 7